METHODS AND SYSTEMS FOR PREDICTING ADHERENCE TO MULTIPLE SCLEROSIS TREATMENT

Patent №

US 10,691,776

Granted

2020-06-23

Filed 2013

Owner

EXPRESS SCRIPTS, INC.

Lab

AI components

3

ml · kr · planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

13969707

Methods and systems for predicting adherence to Multiple Sclerosis treatment are described. In one embodiment, a member undergoing a Multiple Sclerosis treatment is identified. Member data associated with the member undergoing the Multiple Sclerosis treatment is accessed. Pre-prediction time period adherence data associated with the member, member prescription data associated with the member, member family data associated with the member, and member demographic data associated with the member are determined based on the member data associated with the member. A likelihood that the member will be adherent to the Multiple Sclerosis treatment over a prediction time period is determined based on the pre-prediction time period adherence data, member prescription data, member family data, and member demographic data. Other methods and systems are described.

AI classification

Planning1.00
Machine learning1.00
Knowledge representation0.65
Evolutionary computation0.39
Vision0.11
Natural language0.10
AI hardware0.03
Speech0.00

Ownership

EXPRESS SCRIPTS, INC.

assignment · 317250827

Assignors

TOMALA, DAVID ALFREDO, FOLLIS, SEDA AYDIN, KATRAGADDA, SUMAN

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC